Physician profile
Shereen I Oloufa
NPI 1669560751
$9,384.99
in general payments reported to CMS, 2019-2025
32 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,842 · 2020: $405 · 2021: $241 · 2022: $236 · 2023: $192 · 2024: $141 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,957.86 | 2019-2021 | |
| Convatec INC. | $3,251.60 | 2019 | |
| Abbvie INC. | $346.22 | 2019-2022 | |
| Therapeuticsmd, INC. | $234.59 | 2019-2022 | |
| Medical Device Business Services, INC. | $229.62 | 2020-2025 | Vistaseal |
| Mayne Pharma Commercial LLC | $156.07 | 2022-2025 | |
| Millicent US INC | $143.10 | 2019-2025 | Intrarosa, Femring |
| Hologic Sales and Service, LLC | $131.91 | 2019-2025 | Thinprep 2000 Processor, Aptima, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Cumberland Pharmaceuticals, INC. | $125.02 | 2019 | |
| Gauss Surgical INC. | $99.87 | 2019 | |
| Exeltis, USA INC. | $99.85 | 2019-2023 | Slynd |
| Amgen INC. | $72.22 | 2019-2024 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $53.40 | 2019-2025 | |
| Daiichi Sankyo INC. | $50.11 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $48.25 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $36.12 | 2019-2023 | |
| Applied Medical Resources Corporation | $35.48 | 2022 | |
| Lupin INC. | $33.28 | 2019 | |
| Conmed Corporation | $32.48 | 2024 | Airseal |
| Organon LLC | $31.67 | 2023-2024 | Nexplanon |
| Pfizer INC. | $31.62 | 2022-2023 | |
| Astellas Pharma US INC | $25.17 | 2023 | Veozah |
| Novo Nordisk INC | $21.75 | 2023 | |
| Gynesonics, INC. | $17.56 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $16.43 | 2022 | |
| Amag Pharmaceuticals, INC. | $16.39 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.11 | 2020 | |
| Dysis Medical, INC. | $15.87 | 2019 | |
| Sumitomo Pharma America, INC. | $14.42 | 2023 | Myfembree |
| Boston Scientific Corporation | $13.79 | 2021 | |
| Sanofi Pasteur INC. | $13.76 | 2019 | |
| Coopersurgical, INC. | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shereen Oloufa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.